A Study On Risk Management Of Accounts Receivable In HSZY Companies

With the aggravation of population aging,the implementation of comprehensive two-child policy and the sudden occurrence of uncontrollable epidemic disasters,people pay more attention to their own health problems.The pharmaceutical industry is an important industry related to people’s livelihood and health,and the implementation of medical policies such as medical insurance control fees,drug addition and "two-vote system" and the introduction of imported drugs have made foreign drug prices lower and become the first choice for more patients,leading to the reduction of profits of domestic pharmaceutical enterprises and intensifying competition in the domestic pharmaceutical industry.In the case of increasingly fierce market competition,domestic enterprises in order to enhance their core competitiveness,one after another to expand external sales,credit sales in the enterprise’s share of external sales gradually increased,accounts receivable in the enterprise’s current assets in the proportion increased,bad debts also increased.In this way,pharmaceutical enterprises to accounts receivable risk management is particularly important.The risk management of accounts receivable is an old problem that has plagued the healthy management of enterprises for many years.Due to the lag of market mechanism and legal environment construction,most enterprises have some deficiencies in the risk management of accounts receivable.There are three points in general: first,there is no corresponding evaluation and improvement of the risk management of accounts receivable,resulting in the proportion and amount of accounts receivable can not reach the best state;second,accounts receivable occupy most of the current assets to make the enterprise capital chain shortage;third,the risk management of accounts receivable has not established a complete risk management system,the responsibilities of internal personnel and the various management links do not pay attention to coordination.These problems will bring risks to the accountsreceivable of enterprises,thus affecting the normal production and operation of enterprises.How to manage the enterprise accounts receivable scientifically and effectively,reduce the risk caused by bad debts and improve the efficiency of the use of funds is an important subject of the current enterprise accounts receivable risk management.As the key high-tech enterprise of the National Torch Program and the leading enterprise of the national biological industry base,HSZY company has certain typical significance in the pharmaceutical industry.In recent years,the company’s total accounts receivable and its proportion of operating income and current assets show a rising trend,in order to make the enterprise more accurate management of internal and external risk factors of accounts receivable.Based on the situation of HSZY company’s accounts receivable risk management,this paper uses literature analysis,case analysis and other methods,combined with the company’s financial data for nearly six years from 2013 to 2018,to identify the internal and external risk factors of the company’s accounts receivable,and then use the analytic hierarchy process and expert scoring method to evaluate the weight according to the proportion of risk factors and scoring results,put forward the corresponding optimization measures of the risk management of accounts receivable,to achieve the purpose of reducing the risk of enterprise accounts receivable bad debts and other risk purposes,improve the liquidity of enterprise’s current assets and improve the phenomenon of overdue bad debts of accounts receivable.